Core Laboratories N.V. (CLB) Sets 52-Week High

May 16, 2018 - By Madeline Delgado

Core Laboratories N.V. (NYSE:CLB) Corporate Logo

During Q4 2017 the big money sentiment decreased to 0.86. That’s change of 0.21, from 2017Q3’s 1.07. 52 investors sold all, 109 reduced holdings as Core Laboratories N.V. ratio fall. 85 increased stakes while 54 funds amassed stakes. Funds hold 49.56 million shares thus 0.63% more from 2017Q3’s 49.25 million shares.
Oxbow Advsrs Ltd Com owns 36,764 shs. Ny State Common Retirement Fund holds 0.02% or 155,559 shs. Sg Americas Securities Limited Liability Corporation owns 13,788 shs. Kbc Group Inc Nv accumulated 356 shs. Lazard Asset Mgmt Limited Liability holds 0.07% or 314,039 shs. Banced holds 0.62% or 3,411 shs. State Bank Of America De holds 348,115 shs or 0.01% of its capital. M&T Commercial Bank reported 46,073 shs. Ariel Limited Liability reported 0.61% in Core Laboratories N.V. (NYSE:CLB). Aqr Capital Mngmt Lc has 0.01% invested in Core Laboratories N.V. (NYSE:CLB) for 48,101 shs. Fdx reported 16,263 shs. Needham Mngmt Limited Com invested in 500 shs. Ngam Advsrs L P owns 172,727 shs or 0.19% of their US capital. Timessquare Capital Mngmt Ltd Liability Corp stated it has 0.21% of its capital in Core Laboratories N.V. (NYSE:CLB). Shine Advisory reported 0.07% of its capital in Core Laboratories N.V. (NYSE:CLB).

Core Laboratories N.V. (NYSE:CLB) having $126.33 stock price and $131.38 price target reached yearly high. The yearly high was reported on May, 16 by Core Laboratories N.V. (NYSE:CLB) has $5.58B market cap. At our $131.38 price target, the company worth will be $223.36 million more.

CLB is hitting $126.33 during the last trading session, after increased 1.87%.Currently Core Laboratories N.V. is downtrending after 4.05% change in last May 16, 2017. CLB has 211,444 shares volume. CLB underperformed the S&P500 by 15.60%.

Core Laboratories N.V. (NYSE:CLB)’s earnings release is expected by WallStreet on July, 23, according to Faxor. Analysts forecast $0.65 earnings per share. That’s $0.13 up or 25.00 % from 2017’s earnings of $0.52. If earnings per share of $0.65 is reported the profit of CLB could hit $28.73 million giving it 48.59 P/E. Last quarter $0.57 earnings per share was reported. Analysts forecasts 14.04 % EPS growth this quarter.

Core Laboratories N.V. (NYSE:CLB) Ratings Coverage

A total of 5 analysts rate Core Laboratories (NYSE:CLB) as follows: 1 “Buy”, 4 “Hold” and 0 “Sell”. Тherefore 20% are bullish. The firm has $125.0 highest and $96.0 lowest target. The avg target $110.20 is -12.77% below the last ($126.33) price. (NYSE:CLB) has 6 ratings reports on May 16, 2018 according to StockzIntelligence. On Monday, January 29 the firm earned “Buy” rating by RBC Capital Markets. On Thursday, December 21 the firm has “Buy” rating by RBC Capital Markets given. On Monday, April 30 the firm earned “Neutral” rating by Citigroup. On Thursday, January 11 the stock has “Hold” rating by Deutsche Bank. The stock rating was maintained by Cowen & Co with “Hold” on Friday, April 13. On Tuesday, March 13 Piper Jaffray initiated the shares of CLB in report with “Hold” rating.

For more Core Laboratories N.V. (NYSE:CLB) news posted briefly go to:,,, or The titles are as follows: “Oil Stocks: Why This Time Is Different” posted on May 12, 2018, “Core Labs Earnings Preview” on April 25, 2018, “3 Energy Stocks to Buy in May” with a publish date: May 15, 2018, “Core Labs: Stock Price Continues To Confound Its Intrinsic Value” and the last “Core Laboratories Remains Highly Overvalued” with publication date: April 29, 2018.

Core Laboratories N.V. provides reservoir description, production enhancement, and reservoir management services to the gas and oil industry in the United States, Canada, and internationally.The firm is worth $5.58 billion. It operates through three divisions: Reservoir Description, Production Enhancement, and Reservoir Management.67.2 is the P/E ratio. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples.

Core Laboratories N.V. (NYSE:CLB) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: